| 4542- | AgNPs, | Silver Nanoparticles (AgNPs): Comprehensive Insights into Bio/Synthesis, Key Influencing Factors, Multifaceted Applications, and Toxicity─A 2024 Update |
| - | Review, | Var, | NA |
| 4541- | AgNPs, | RosA, | Eco-friendly synthesis of silver nanoparticles: multifaceted antioxidant, antidiabetic, anticancer, and antimicrobial activities |
| - | in-vitro, | Nor, | WI38 | - | in-vitro, | BC, | MDA-MB-231 | - | in-vitro, | PC, | PANC1 |
| 4540- | AgNPs, | VitC, | Silver nanoparticles from ascorbic acid: Biosynthesis, characterization, in vitro safety profile, antimicrobial activity and phytotoxicity |
| - | in-vitro, | Nor, | NA |
| 4539- | AgNPs, | VitC, | Citrate, | Investigating the Anti-cancer Potential of Silver Nanoparticles Synthesized by Chemical Reduction of AgNO3 Using Trisodium Citrate and Ascorbic Acid |
| - | in-vitro, | Nor, | L929 | - | in-vitro, | Ovarian, | SKOV3 |
| 4586- | AgNPs, | Tyndall-effect-enhanced supersensitive naked-eye determination of mercury (II) ions with silver nanoparticles |
| - | Study, | Var, | NA |
| 4600- | AgNPs, | Effects of particle size and coating on toxicologic parameters, fecal elimination kinetics and tissue distribution of acutely ingested silver nanoparticles in a mouse model |
| - | in-vivo, | Nor, | NA |
| 4599- | AgNPs, | ProBio, | Impacts of dietary silver nanoparticles and probiotic administration on the microbiota of an in-vitro gut model |
| - | in-vivo, | Nor, | NA |
| 4598- | AgNPs, | In vivo human time-exposure study of orally dosed commercial silver nanoparticles |
| - | in-vivo, | Nor, | NA |
| 4596- | AgNPs, | Oral administration of silver nanomaterials affects the gut microbiota and metabolic profile altering the secretion of 5-HT in mice |
| - | in-vivo, | Nor, | NA |
| 4595- | AgNPs, | ORAL DELIVERY OF SILVER NANOPARTICLES – A REVIEW |
| - | Review, | Nor, | NA |
| 4594- | AgNPs, | Citrate, | Bioavailability and Toxicokinetics of citrate-coated silver nanoparticles in rats |
| - | in-vivo, | Nor, | NA |
| 4593- | AgNPs, | Chit, | Chitosan-coated silver nanoparticles promoted antibacterial, antibiofilm, wound-healing of murine macrophages and antiproliferation of human breast cancer MCF 7 cells |
| - | in-vitro, | BC, | MCF7 |
| 4592- | AgNPs, | Chit, | Chitosan conjugated silver nanoparticles: the versatile antibacterial agents |
| - | in-vitro, | Nor, | NA |
| 4591- | AgNPs, | Chit, | Synthesis and Characterization of Multifunctional Chitosan–Silver Nanoparticles: An In-Vitro Approach for Biomedical Applications |
| - | in-vitro, | Nor, | NA |
| 4590- | AgNPs, | Chit, | Silver nanochitosan: a sustainable approach for enhanced antimicrobial, antioxidant, and anticancer applications |
| - | in-vitro, | Var, | NA |
| 4589- | AgNPs, | Chit, | Synthesis and Characterization of Chitosan–Silver Nanocomposite Film: Antibacterial and Cytotoxicity Study |
| - | in-vitro, | Var, | NA |
| 4588- | AgNPs, | Chit, | Solid-state tailored silver nanocomposites from chitosan: Synthesis, antimicrobial evaluation and molecular docking |
| - | in-vitro, | Var, | NA |
| 4587- | AgNPs, | Chit, | Multifunctional Silver Nanoparticles Based on Chitosan: Antibacterial, Antibiofilm, Antifungal, Antioxidant, and Wound-Healing Activities |
| - | in-vitro, | Var, | NA |
| 4573- | AgNPs, | Bioactive silver nanoparticles derived from Carica papaya floral extract and its dual-functioning biomedical application |
| - | in-vitro, | Var, | MCF7 | - | NA, | NA, | HEK293 |
| 4585- | AgNPs, | Tyndall-effect-based colorimetric assay with colloidal silver nanoparticles for quantitative point-of-care detection of creatinine using a laser pointer pen and a smartphone |
| - | Study, | Var, | NA |
| 4584- | AgNPs, | Silver Nanoparticles Synthesized Using Carica papaya Leaf Extract (AgNPs-PLE) Causes Cell Cycle Arrest and Apoptosis in Human Prostate (DU145) Cancer Cells |
| - | in-vitro, | Pca, | DU145 |
| 4583- | AgNPs, | Metal-Based Nanoparticles for Cardiovascular Diseases |
| - | Review, | CardioV, | NA |
| 4582- | AgNPs, | Silver CASRN 7440-22-4 | DTXSID4024305 |
| - | Study, | Var, | NA |
| 4581- | AgNPs, | Antimicrobial, anticoagulant and antiplatelet activities of green synthesized silver nanoparticles using Selaginella (Sanjeevini) plant extract |
| - | Study, | Nor, | NA |
| 4580- | AgNPs, | Biogenic Synthesis of Antibacterial, Hemocompatible, and Antiplatelets Lysozyme Functionalized Silver Nanoparticles through the One-Step Process for Therapeutic Applications |
| - | in-vitro, | Nor, | NA |
| 4579- | AgNPs, | Response of platelets to silver nanoparticles designed with different surface functionalization |
| - | in-vitro, | Nor, | NA |
| 4578- | AgNPs, | Green synthesized novel silver nanoparticles and their application as anticoagulant and thrombolytic agents: A perspective |
| - | Review, | Nor, | NA |
| 4577- | AgNPs, | Characterization of Antiplatelet Properties of Silver Nanoparticles |
| - | vitro+vivo, | Stroke, | NA |
| 4576- | AgNPs, | Nanosilver, Next-Generation Antithrombotic Agent |
| - | Study, | Nor, | NA |
| 4574- | AgNPs, | Advances in nano silver-based biomaterials and their biomedical applications |
| - | Review, | Nor, | NA |
| 5147- | AgNPs, | Size dependent anti-invasiveness of silver nanoparticles in lung cancer cells |
| - | in-vitro, | Lung, | A549 |
| 5146- | AgNPs, | Silver Nanoparticle-Induced Autophagic-Lysosomal Disruption and NLRP3-Inflammasome Activation in HepG2 Cells Is Size-Dependent |
| - | in-vitro, | Liver, | HepG2 |
| 5145- | AgNPs, | Silver nanoparticles induce irremediable endoplasmic reticulum stress leading to unfolded protein response dependent apoptosis in breast cancer cells |
| - | in-vitro, | BC, | MCF7 | - | in-vitro, | BC, | T47D |
| 5144- | AgNPs, | Differential effects of silver nanoparticles on DNA damage and DNA repair gene expression in Ogg1-deficient and wild type mice |
| - | in-vivo, | Nor, | NA |
| - | in-vitro, | CRC, | HCT116 |
| 5142- | AgNPs, | Biosynthesized Protein-Capped Silver Nanoparticles Induce ROS-Dependent Proapoptotic Signals and Prosurvival Autophagy in Cancer Cells |
| - | in-vitro, | CRC, | HUH7 |
| 4392- | AgNPs, | Hepatocurative activity of biosynthesized silver nanoparticles fabricated using Andrographis paniculata |
| - | in-vivo, | LiverDam, | NA |
| 4402- | AgNPs, | Enhancement of Triple-Negative Breast Cancer-Specific Induction of Cell Death by Silver Nanoparticles by Combined Treatment with Proteotoxic Stress Response Inhibitors |
| - | in-vitro, | BC, | BT549 | - | in-vitro, | BC, | MDA-MB-231 | - | in-vitro, | Nor, | MCF10 |
| 4401- | AgNPs, | Rad, | Metformin-loaded chitosan nanoparticles augment silver nanoparticle-induced radiosensitization in breast cancer cells during radiation therapy |
| - | in-vitro, | BC, | NA |
| 4400- | AgNPs, | Rad, | Differential cytotoxic and radiosensitizing effects of silver nanoparticles on triple-negative breast cancer and non-triple-negative breast cells |
| - | in-vitro, | BC, | MCF7 | - | in-vitro, | Nor, | MCF10 | - | in-vitro, | BC, | MDA-MB-231 | - | in-vitro, | BC, | BT549 | - | in-vivo, | BC, | MDA-MB-231 |
| 4399- | AgNPs, | Chit, | Silver nanoparticles impregnated alginate-chitosan-blended nanocarrier induces apoptosis in human glioblastoma cells |
| - | in-vitro, | GBM, | U87MG |
| 4398- | AgNPs, | Induction of apoptosis in cancer cells at low silver nanoparticle concentrations using chitosan nanocarrier |
| - | in-vitro, | Colon, | HT29 |
| 4397- | AgNPs, | Synthesis and Characterization of Silver Nanoparticles from Rhizophora apiculata and Studies on Their Wound Healing, Antioxidant, Anti-Inflammatory, and Cytotoxic Activity |
| - | Study, | Wounds, | NA |
| - | in-vitro, | OS, | MG63 |
| 4395- | AgNPs, | Hepatoprotective effect of silver nanoparticles synthesized using aqueous leaf extract of Rhizophora apiculata |
| - | in-vivo, | LiverDam, | NA |
| 4394- | AgNPs, | Silver nanoparticles provoke apoptosis of Dalton's ascites lymphoma in vivo by mitochondria dependent and independent pathways |
| - | in-vivo, | lymphoma, | NA |
| 4393- | AgNPs, | Nanotoxic Effects of Silver Nanoparticles on Normal HEK-293 Cells in Comparison to Cancerous HeLa Cell Line |
| - | in-vitro, | Cerv, | HeLa | - | in-vitro, | Nor, | HEK293 |
| 4403- | AgNPs, | Silver Nanoparticles Decorated UiO-66-NH2 Metal-Organic Framework for Combination Therapy in Cancer Treatment |
| - | in-vitro, | GBM, | U251 | - | in-vitro, | GBM, | U87MG | - | in-vitro, | GBM, | GL26 | - | in-vitro, | Cerv, | HeLa | - | in-vitro, | CRC, | RKO |
| 4391- | AgNPs, | Silver Nanoparticles Induce Apoptosis in HepG2 Cells through Particle-Specific Effects on Mitochondria |
| - | in-vitro, | Liver, | HepG2 |
| 4390- | AgNPs, | Therapeutic Potential of Cucumis melo (L.) Fruit Extract and Its Silver Nanopartciles Against DEN-Induced Hepatocellular Cancer in Rats |
| - | in-vivo, | Liver, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:% State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid